Research on thymoquinone, the active compound in black seed oil, has shown promising results in managing diabetes. Clinical trials and animal studies suggest that Nigella sativa (black seed) can improve glycemic control, reduce oxidative stress, and offer protective benefits for diabetic complications.
Dosages of Nigella sativa (NS) vary widely depending on the form ingested (seed or oil). Most clinical trials administering oral doses to adults have used between 500 mg to 3 grams or 5 mL of NS oil daily without significant adverse events. It’s crucial to consider the standardization of the preparation. If using NS oil standardized to 3% thymoquinone (more concentrated than most commercially available material), smaller doses should be effective.